1. Home
  2. CENX vs HTFL Comparison

CENX vs HTFL Comparison

Compare CENX & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Aluminum Company

CENX

Century Aluminum Company

HOLD

Current Price

$36.03

Market Cap

2.7B

Sector

Industrials

ML Signal

HOLD

HTFL

Heartflow Inc.

N/A

Current Price

$30.62

Market Cap

2.4B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CENX
HTFL
Founded
1995
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Aluminum
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.4B
IPO Year
1996
2025

Fundamental Metrics

Financial Performance
Metric
CENX
HTFL
Price
$36.03
$30.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$33.00
$39.50
AVG Volume (30 Days)
1.9M
733.8K
Earning Date
11-06-2025
02-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.83
N/A
Revenue
$2,525,100,000.00
$161,881,000.00
Revenue This Year
$16.07
$40.42
Revenue Next Year
N/A
$22.27
P/E Ratio
$43.42
N/A
Revenue Growth
20.15
85.70
52 Week Low
$13.05
$25.38
52 Week High
$37.05
$41.22

Technical Indicators

Market Signals
Indicator
CENX
HTFL
Relative Strength Index (RSI) 71.87 N/A
Support Level $31.71 N/A
Resistance Level $33.06 N/A
Average True Range (ATR) 1.52 0.00
MACD 0.50 0.00
Stochastic Oscillator 86.85 0.00

Price Performance

Historical Comparison
CENX
HTFL

About CENX Century Aluminum Company

Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. Century purchases nearly all of its alumina from Glencore. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. Century also owns a carbon anode production facility in the Netherlands.

About HTFL Heartflow Inc.

HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.

Share on Social Networks: